SignatureFD’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.1K | Sell |
1,613
-10
| -0.6% | -$534 | ﹤0.01% | 1305 |
|
|
2025
Q1 | $65.7K | Buy |
1,623
+45
| +3% | +$1.82K | ﹤0.01% | 1420 |
|
|
2024
Q4 | $43.9K | Hold |
1,578
| – | – | ﹤0.01% | 1647 |
|
|
2024
Q3 | $45.3K | Buy |
1,578
+58
| +4% | +$1.66K | ﹤0.01% | 1624 |
|
|
2024
Q2 | $35.7K | Buy |
1,520
+20
| +1% | +$469 | ﹤0.01% | 1676 |
|
|
2024
Q1 | $37.9K | Buy |
1,500
+17
| +1% | +$429 | ﹤0.01% | 1687 |
|
|
2023
Q4 | $34.6K | Sell |
1,483
-507
| -25% | -$11.8K | ﹤0.01% | 1651 |
|
|
2023
Q3 | $101K | Sell |
1,990
-9
| -0.5% | -$455 | ﹤0.01% | 1057 |
|
|
2023
Q2 | $93.3K | Sell |
1,999
-31
| -2% | -$1.45K | ﹤0.01% | 1098 |
|
|
2023
Q1 | $77.7K | Sell |
2,030
-142
| -7% | -$5.43K | ﹤0.01% | 1172 |
|
|
2022
Q4 | $119K | Buy |
2,172
+121
| +6% | +$6.63K | ﹤0.01% | 920 |
|
|
2022
Q3 | $70K | Buy |
2,051
+1,335
| +186% | +$45.6K | ﹤0.01% | 1121 |
|
|
2022
Q2 | $7K | Buy |
716
+595
| +492% | +$5.82K | ﹤0.01% | 2266 |
|
|
2022
Q1 | $2K | Buy |
+121
| New | +$2K | ﹤0.01% | 2753 |
|
|
2021
Q4 | – | Sell |
-48
| Closed | -$1K | – | 3088 |
|
|
2021
Q3 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 2755 |
|